BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29691806)

  • 1. Phosphoproteome profiling revealed abnormally phosphorylated AMPK and ATF2 involved in glucose metabolism and tumorigenesis of GH-PAs.
    Zhao S; Feng J; Li C; Gao H; Lv P; Li J; Liu Q; He Y; Wang H; Gong L; Li D; Zhang Y
    J Endocrinol Invest; 2019 Feb; 42(2):137-148. PubMed ID: 29691806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
    Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
    J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential biomarkers and lncRNA-mRNA regulatory networks in invasive growth hormone-secreting pituitary adenomas.
    Yin H; Zheng X; Tang X; Zang Z; Li B; He S; Shen R; Yang H; Li S
    J Endocrinol Invest; 2021 Sep; 44(9):1947-1959. PubMed ID: 33559847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
    Garcia EA; Trivellin G; Aflorei ED; Powell M; Grieve J; Alusi G; Pobereskin L; Shariati B; Cudlip S; Roncaroli F; Mendoza N; Grossman AB; Harper EA; Korbonits M
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1918-26. PubMed ID: 24152687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of AMPK activation and combined treatment with AMPK activators and somatostatin on hormone secretion and cell growth in cultured GH-secreting pituitary tumor cells.
    Tulipano G; Faggi L; Losa M; Mortini P; Spinello M; Sibilia V; Pagani F; Cocchi D; Giustina A
    Mol Cell Endocrinol; 2013 Jan; 365(2):197-206. PubMed ID: 23116772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells.
    Peverelli E; Giardino E; Mangili F; Treppiedi D; Catalano R; Ferrante E; Sala E; Locatelli M; Lania AG; Arosio M; Spada A; Mantovani G
    Cancer Lett; 2018 Oct; 435():101-109. PubMed ID: 30098401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) and guanylate kinase 1 (GUK1) are differentially expressed in GH-secreting adenomas.
    da Rocha AA; Giorgi RR; de Sa SV; Correa-Giannella ML; Fortes MA; Cavaleiro AM; Machado MC; Cescato VA; Bronstein MD; Giannella-Neto D
    Pituitary; 2006; 9(2):83-92. PubMed ID: 16832584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation-Mediated Molecular Pathway Changes in Human Pituitary Neuroendocrine Tumors Identified by Quantitative Phosphoproteomics.
    Li J; Wen S; Li B; Li N; Zhan X
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals.
    Faggi L; Giustina A; Tulipano G
    Mol Cell Endocrinol; 2018 Jul; 470():60-74. PubMed ID: 28962892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of Proteomics and Metabolomics Revealed Metabolite-Protein Networks in ACTH-Secreting Pituitary Adenoma.
    Feng J; Zhang Q; Zhou Y; Yu S; Hong L; Zhao S; Yang J; Wan H; Xu G; Zhang Y; Li C
    Front Endocrinol (Lausanne); 2018; 9():678. PubMed ID: 30532734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR is frequently active in GH-secreting pituitary adenomas without influencing their morphopathological features.
    Sajjad EA; Zieliński G; Maksymowicz M; Hutnik Ł; Bednarczuk T; Włodarski P
    Endocr Pathol; 2013 Mar; 24(1):11-9. PubMed ID: 23296986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas.
    Gatto F; Feelders RA; Franck SE; van Koetsveld PM; Dogan F; Kros JM; Neggers SJCMM; van der Lely AJ; Lamberts SWJ; Ferone D; Hofland LJ
    J Clin Endocrinol Metab; 2017 Jun; 102(6):2009-2018. PubMed ID: 28323931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SAGE analysis highlights the putative role of underexpression of ribosomal proteins in GH-secreting pituitary adenomas.
    de Lima DS; Martins CS; Paixao BM; Amaral FC; Colli LM; Saggioro FP; Neder L; Machado HR; dos Santos AR; Pinheiro DG; Moreira AC; Silva WA; Castro M
    Eur J Endocrinol; 2012 Dec; 167(6):759-68. PubMed ID: 22992986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas.
    Giuffrida G; D'Argenio V; Ferraù F; Lasorsa VA; Polito F; Aliquò F; Ragonese M; Cotta OR; Alessi Y; Oteri R; Di Maggio F; Asmundo A; Romeo PD; Spagnolo F; Pastore L; Angileri FF; Capasso M; Cannavò S; Aguennouz M
    Front Endocrinol (Lausanne); 2022; 13():841118. PubMed ID: 35432200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1.
    D'Angelo D; Palmieri D; Mussnich P; Roche M; Wierinckx A; Raverot G; Fedele M; Croce CM; Trouillas J; Fusco A
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1128-38. PubMed ID: 22564666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene and protein expression in pituitary corticotroph adenomas: a systematic review of the literature.
    Seltzer J; Ashton CE; Scotton TC; Pangal D; Carmichael JD; Zada G
    Neurosurg Focus; 2015 Feb; 38(2):E17. PubMed ID: 25639319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly.
    Schwyzer L; Starke RM; Jane JA; Oldfield EH
    J Neurosurg; 2015 Apr; 122(4):798-802. PubMed ID: 25423276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanin-concentrating hormone stimulates human growth hormone secretion: a novel effect of MCH on the hypothalamic-pituitary axis.
    Segal-Lieberman G; Rubinfeld H; Glick M; Kronfeld-Schor N; Shimon I
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E982-8. PubMed ID: 16603725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P27/CDKN1B Translational Regulators in Pituitary Tumorigenesis.
    Martins CS; Camargo RC; Saggioro FP; Neder L; Machado HR; Moreira AC; de Castro M
    Horm Metab Res; 2016 Dec; 48(12):840-846. PubMed ID: 27824399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
    Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.